Related references
Note: Only part of the references are listed.Surgical Cytoreduction and HITOC for Thymic Malignancies with Pleural Dissemination
Till Markowiak et al.
THORACIC AND CARDIOVASCULAR SURGEON (2021)
Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma
Tammy Hod et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)
Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
Tommi Jarvinen et al.
CANCERS (2021)
Hyperthermic intrathoracic chemotherapy (HITHOC): narrative review of the current literature, recommendations and future studies
Till Markowiak et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Arnaud Scherpereel et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany
Till Markowiak et al.
BMJ OPEN (2020)
Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma
Laura Klotz et al.
JOURNAL OF THORACIC DISEASE (2019)
Adequate nephroprotection reduces renal complications after hyperthermic intrathoracic chemotherapy
Till Markowiak et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience
Marcello Carlo Ambrogi et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma
Bryan M. Burt et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Surgery in Malignant Pleural Mesothelioma
Raphael Bueno et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project
Bernhard Moser et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2017)
Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion A systematic review and meta-analysis
Hua Zhou et al.
MEDICINE (2017)
Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
N. Girard et al.
ANNALS OF ONCOLOGY (2015)
Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure
Michael Ried et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2015)
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma
Christopher Cao et al.
LUNG CANCER (2014)
Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience
Michael Ried et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2013)
Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies
M. Ried et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread: A single-institution experience
Alon Yellin et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: Meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass
Valerie Rusch et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection
David J. Sugarbaker et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group
David Rice et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study
Tamara R. Tilleman et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma
Lambros Zellos et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Sequential amifostine and sodium thiosulfate improve renal protection during intracavitary high-dose cisplatin lavage
W. G. Richards et al.
LUNG CANCER (2006)
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma
WG Richards et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Macroscopic complete resection: The goal of primary surgery in multimodality therapy for pleural mesothelioma
David J. Sugarbaker
JOURNAL OF THORACIC ONCOLOGY (2006)
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
R Bellomo et al.
CRITICAL CARE (2004)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies
DJ Sugarbaker et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
Share Paper
